The Effect of Vitamin E on the Treatment of Asthma in Children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201106126660N2

Enrollment

300

Registered

2011-07-20

Start date

2011-02-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate Asthma. Asthma

Interventions

Intervention 1: Vitamine - E (50 mg/day). Intervention 2: Placebo (Suger) for 8 Weeks.

Treatment - Drugs

Placebo

Vitamine - E (50 mg/day)

Placebo (Suger) for 8 Weeks

Eligibility

Sex/Gender

All

Age

5 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: moderate asthma; asthma more than one year; FEV1<80%; Age 5-17 years old. Exclusion criteria: recent sinusitis, pneumonia and other acute infection; heart, kidney, liver and thyroid diseases; intake of Vitamins or Trace elements.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cinical Manifestation of Asthma. Timepoint: 8 Weeks. Method of measurement: Observation.;Spirometry. Timepoint: 8 weeks. Method of measurement: Spirometer.	—

Secondary

Measure	Time frame
Total IgE. Timepoint: 8 Weeks. Method of measurement: Laboratory Test.;Eosinophil. Timepoint: 8 Weeks. Method of measurement: Laboratory Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Javad Ghafari

Mazandaran University of Medical Sciences

javadneg@yahoo.com , ghafari@mazums.ac.ir+98 15 1223 3011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026